Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Sanofi - American Depositary Shares (NQ:SNY)

45.03 -1.19 (-2.56%)

Streaming Delayed Price Updated: 2:41 PM EST, Mar 5, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	2,849,407
Open	45.18
Bid (Size)	45.03 (200)
Ask (Size)	45.04 (200)
Prev. Close	46.22
Today's Range	44.71 - 45.34
52wk Range	44.62 - 60.12
Shares Outstanding	1,250,690,553
Dividend Yield	4.91%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

The Best Healthcare Stock to Invest $1,000 in Right Now ↗

March 02, 2026

There's nothing generic about this drugmaker's recent performance and continued prospects.

Via The Motley Fool

The Great Pivot: Inside Novavax’s 2026 Turnaround and the Road to Combination Vaccines

February 27, 2026

As of today, February 27, 2026, the biotech sector is witnessing a dramatic reappraisal of one of its most storied pandemic-era players. Novavax (NASDAQ: NVAX) has surged 17.4% following the release of...

Via Finterra

Performance

YTD	-6.6%	-6.6%
1 Month	-4.7%	-4.7%
3 Month	-9.4%	-9.4%
6 Month	-9.7%	-9.7%
1 Year	-21.9%	-21.9%

More News

AstraZeneca’s Strategic Leap: Pharmaceutical Giant Completes Historic Move to the New York Stock Exchange

February 26, 2026

Via MarketMinute

Disc Medicine, Sanofi, Eli Lilly Shares Slip On Reports Of FDA Increasing Review Time For Drugs Granted Priority Review Vouchers ↗

January 15, 2026

Via Stocktwits

European Commission Grants Marketing Authorization to Cytokinetics for Cardiac Drug MYQORZO

February 23, 2026

Via MarketMinute

1 No-Brainer Biotech Stock To Buy Today and Never Sell ↗

February 21, 2026

Via The Motley Fool

Moderna’s mRNA Renaissance: Navigating Volatility and the Post-Pandemic Pipeline

February 17, 2026

Via Finterra

Sanofi Tightens Grip on Ocular Therapeutix with Revised Bid as Pivotal SOL-1 Trial Results Loom

February 16, 2026

Via MarketMinute

Alnylam Pharmaceuticals (ALNY): The RNAi Pioneer’s 2026 Breakout and the Battle for Cardiovascular Dominance

February 12, 2026

Via Finterra

FDA Stuns Moderna with Refusal to Review Flu Vaccine, Sending Shares Tumbling 3.5%

February 12, 2026

Via MarketMinute

This Infrastructure Stock Surged Nearly 40% in One Year -- and One Fund Sold $11 Million in Shares ↗

January 29, 2026

Via The Motley Fool

Lilly Bolsters Immunology Arsenal with $1.2 Billion Acquisition of Ventyx Biosciences

January 28, 2026

Via MarketMinute

Eli Lilly Reinforces Immunology Dominance with $1.2 Billion Acquisition of Ventyx Biosciences

January 27, 2026

Via MarketMinute

Nasdaq, S&P 500 Futures Subdued Ahead Of PMI Data: Why INTC, TSLA, NFLX, VST, MOVE Are On Traders' Radar Today ↗

January 23, 2026

Via Stocktwits

AstraZeneca Signals End of an Era: Formal Move to NYSE Triggers Major Index Rebalancing

January 20, 2026

Via MarketMinute

GSK Challenges Xolair Dominance with $2.2 Billion Acquisition of RAPT Therapeutics

January 20, 2026

Via MarketMinute

The Battle for the White Coat: OpenAI and Anthropic Reveal Dueling Healthcare Strategies

January 19, 2026

Via TokenRing AI

Anthropic’s New Specialized Healthcare Tiers: A New Era for AI-Driven Diagnostics and Medical Triage

January 19, 2026

Via TokenRing AI

The mRNA 2.0 Inflection: A Deep Dive into Moderna (MRNA) as it Faces a Critical 2026

January 16, 2026

Via Finterra

Eli Lilly’s $1.2 Billion Acquisition of Ventyx Biosciences: Bridging the Gap Between Weight Loss and Chronic Inflammation

January 15, 2026

Via MarketMinute

Why Did OCUL Stock Jump 13% In Pre-Market Today? ↗

January 15, 2026

Via Stocktwits

Anthropic Launches “Claude for Healthcare”: A Paradigm Shift in Medical AI Integration and HIPAA Security

January 12, 2026

Via TokenRing AI

Cashing In at the Peak: Olema Pharmaceuticals Insiders Sell $8 Million in Stock After 300% Surge

January 09, 2026

Via MarketMinute

MoonLake Immunotherapeutics Surges as FDA "De-Risks" Sonelokimab, Reigniting Multi-Billion Dollar Takeover Speculation

January 09, 2026

Via MarketMinute

BioNTech Finalizes CureVac Acquisition: A Strategic Consolidation Met with Market Skepticism

January 09, 2026

Via MarketMinute

Frequently Asked Questions

Is Sanofi - American Depositary Shares publicly traded?

Yes, Sanofi - American Depositary Shares is publicly traded.

What exchange does Sanofi - American Depositary Shares trade on?

Sanofi - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Sanofi - American Depositary Shares?

The ticker symbol for Sanofi - American Depositary Shares is SNY on the Nasdaq Stock Market

What is the current price of Sanofi - American Depositary Shares?

The current price of Sanofi - American Depositary Shares is 45.03

When was Sanofi - American Depositary Shares last traded?

The last trade of Sanofi - American Depositary Shares was at 03/05/26 02:41 PM ET

What is the market capitalization of Sanofi - American Depositary Shares?

The market capitalization of Sanofi - American Depositary Shares is 56.32B

How many shares of Sanofi - American Depositary Shares are outstanding?

Sanofi - American Depositary Shares has 56B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.